New study aims to predict heart side effects in kids treated for cancer
NCT ID NCT07253077
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will check if certain blood markers can predict heart damage in children and teens who had anthracycline chemotherapy for cancer. Researchers will compare blood tests and heart imaging results from 40 survivors and healthy volunteers. The goal is to find early warning signs before heart problems develop.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTHRACYCLINE RELATED CARDIOTOXICITY IN CHILDHOOD CANCERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Roma, 00168, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict growth problems in childhood cancer survivors?
- Exercise as medicine: a new weapon in the fight against childhood cancer?
- Olive oil and xylitol mouth rinse may shield cancer patients from painful mouth sores
- Rebooting immunity: can vaccines shield childhood cancer survivors from preventable diseases?
- Can a peer coach help young people take control of their chronic illness?
- Could a 14-Hour overnight fast help childhood cancer survivors?